Followers | 0 |
Posts | 30 |
Boards Moderated | 0 |
Alias Born | 09/20/2022 |
Thursday, October 20, 2022 3:37:45 PM
The company should have filed a S153 which would have seen them if approved no longer being a RI in any jurisdiction in Canada but the odds of that now as I believe instated earlier is an unlikely avenue given the CTO and the other issues potentially facing them.
If you live in Canada and feel you may have been scammed you should file a complaint with the Albert’s Securities Commission and ask them to open an investigation and provide not only your reasons but examples of what you consider to be breaches of the securities act. If you say Mr. Grant did this or said that then provide those examples so they can be looked into. Unsubstantiated complaints do not result in the regulator trying to find an issue based on “it’s a fraud or scam”. They do not go hunting for breaches like that. If you live outside Alberta they will refer your inquiry to Alberta so save time and go to them.
I took a look at SEDAR just now based on a question I received and to date there is nothing there to indicate they have done anything more than post an old unaudited filing to SEDAR.
I have no idea who represents Atacama in Canada. That likely would be the legal counsel to deal with the CTO. In my experiences the process is slow usually do to the inability or lack of co-operation of the reporting issuer to address issues highlighted by the securities analysts handing the file. It is no skin off the regulators nose if the issuer is unable to work progressively to a revocation of the order. It is however skin off the noses of investors trying to trade the stock.
And the final question is I don’t answer based on message boards or limited information to call it a scam. That is the responsibility of the administrative panel and or a judge to decide based upon proof and accepted evidence.
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM